Primary Sclerosing Cholangitis (PSC) is a rare, progressive liver disease characterized by inflammation and scarring of the bile ducts that causes them to narrow. Over time, the bile duct damage caused by PSC prevents the liver from functioning properly. The current treatment landscape focuses on reducing symptoms and managing them effectively. However, there is a pressing need for developing curative treatment options to address its rising prevalence.
The primary sclerosing cholangitis market comprises drugs and treatments to manage the symptoms of primary sclerosing cholangitis, a rare disorder that causes inflammation and scarring in the bile ducts of the liver. Primary sclerosing cholangitis (PSC) is a rare long-term disease that causes narrowing and scarring of the bile ducts inside and outside the liver. Patients with PSC experience itching, jaundice, abdominal pain, fatigue, weight loss, and fever as the disease progresses. The ... Read more
